Study of lipid profile in HIV/AIDS patients on antiretroviral therapy.

Saurabh G Sadekar, SN Bentoor.

dc.contributor.author	Saurabh G Sadekar, SN Bentoor.
dc.date.accessioned	2019-11-06T12:14:27Z
dc.date.available	2019-11-06T12:14:27Z
dc.date.issued	2016
dc.identifier.issn	22293809
dc.identifier.uri	http://hdl.handle.net/123456789/1162
dc.description.abstract	The introduction of effective highly active antiretroviral therapy (HAART) in the mid 1990s lead to the marked reduction in the morbidity and mortality from human immunodeficiency virus (HIV) infection. Increasing life expectancy, an aging population, and high rates of smoking have lead to concerns of the health of HIV infected individuals in the long run. Metabolic effects of HIV infection such as hypertriglyceridemia are well defined and side effects of HAART such as dyslipidemia and were described soon after its introduction.	en_US
dc.language.iso	en	en_US
dc.publisher	BLDE(Deemed to be University)	en_US
dc.subject	HIV, LDL, HDL, antiretroviral drugs.	en_US
dc.title	Study of lipid profile in HIV/AIDS patients on antiretroviral therapy.	en_US
dc.type	Article	en_US